By 
The list of the biggest CPG brands barely moves. Nestlé, PepsiCo, P&G, Unilever, Coca-Cola: the same names sit at the top most years, in roughly the same order. If you only read that list, you would think nothing in consumer goods ever changes.
The list worth studying in 2026 is the other one. The brands taking their growth. That is where a small brand can actually learn something it can use, so this piece covers both: the giants who own the shelf, then the challengers rewriting who deserves to be on it, and what you can steal from each.
CPG brand or CPG company? The distinction everyone blurs
Worth thirty seconds, because most lists mash these together and it changes what you should take from them.
A CPG company owns a portfolio of CPG brands. Procter & Gamble is a company. Tide, Gillette, Pampers and Olay are its brands. When a ranking says “Nestlé” it means the parent that houses hundreds of brands, from KitKat to Purina to Nespresso. When someone says their favourite CPG brand, they mean the thing on the shelf with a logo, not the holding company behind it.
CPG stands for consumer packaged goods: the everyday products people buy often and replace quickly, from food and drink to personal care and cleaning. It is a large, steady sector, which is why CPG market research is a discipline of its own. Investopedia puts the US sector at roughly $2 trillion. That size is exactly why the top of the list is so hard to shift, and why the interesting movement happens further down.
The biggest CPG companies in 2026
Ranked by revenue, the order at the top is familiar. These figures come from each company’s most recent full-year results, each in its own reporting currency, and the Consumer Goods Technology Top 100 ranking.
Nestlé sits first, with CHF 91.35bn in sales in 2024, though that was down 1.8% on the year, which tells you something about the pressure even the leader is under. PepsiCo is next at roughly $91.85bn, then Procter & Gamble at $84.3bn in its 2025 financial year. Unilever reported €60.8bn in turnover for 2024, and Coca-Cola $47.1bn. Below them sit the next tier: AB InBev, JBS, L’Oréal, Mondelez at $36.44bn, Danone, Kraft Heinz, General Mills, Colgate-Palmolive and Kimberly-Clark.
The thing to notice is that none of these is a brand. Each is a cupboard holding dozens of them. Their strength is not a single hero product; it is distribution, supply chain and a portfolio deep enough to survive any one brand going cold. They own the shelf and the relationships with the retailers who control it.
That same scale is their weakness. A company doing tens of billions in revenue cannot get excited about a product line that might do $50m in its first year, even though $50m is a life-changing business for the person who builds it. That gap, between what moves the needle for a giant and what a founder can build, is where every challenger below lives.
The individual brands that still do the heavy lifting
Inside those portfolios, a handful of brands carry an outsized share of the trust. Coca-Cola the brand, not the company, is one of the most valuable names in the world. Dove, Oreo, Tide, Gillette, Pampers, Red Bull and Nespresso are brand-equity machines that took decades and enormous marketing budgets to build. When Comparably ranks consumer-goods brands on how people actually feel about them, it is names like Lego, Red Bull and Colgate that come out on top, not the parent companies.
This is the moat the giants are really defending. Not a formula, which any contract manufacturer can approximate, but a name a shopper reaches for without thinking, which is what all that spending on shopper insights is really chasing. It is slow and expensive to build, which is precisely why an established brand is worth so much and why a challenger has to win a different way.
The challengers taking the growth
Here is the number that reframes the whole list. McKinsey found that established brands accounted for less than half of total category growth in home and hygiene from 2019 to 2024, despite owning most of the volume. In some categories the tilt is starker: disruptor brands now drive 50% or more of growth in bath and body, performance nutrition and grooming, and in pest control two brands, Zevo and STEM, took roughly 70% of the growth and 20 points of share. McKinsey’s later work on what the giants can learn from disruptor brands finds the same pattern repeating across salty snacks, beverages and supplements.
The giants have noticed. That is why every parent company above runs an acquisitions team, and why the most telling CPG stories of the last two years are not launches but purchases.
Prebiotic soda is the clearest case. Olipop launched in 2018 into a category that did not really exist, and by 2024 it was doing around $400m in sales, roughly double the year before, at a $1.85bn valuation. Its rival Poppi grew fast enough that in 2025 PepsiCo bought it for $1.95bn. Two brands, a category that barely existed seven years ago, and one of them is now inside the world’s second-largest CPG company.
Liquid Death sells canned water. On paper that is the least differentiated product imaginable. It reached $333m in revenue in 2024, up 27%, at a $1.4bn valuation by selling the opposite of what a water brand normally sells. Heavy-metal branding, comedy, merchandise, an identity people wanted to be seen holding. The water was almost incidental.
David, a protein bar brand, launched in September 2024 and reached a $725m valuation within nine months. It won on the product itself: more protein per calorie than anything next to it, a claim customers could verify on the pack.
Ghost built an energy brand around community and collaborations rather than a traditional media spend, and in late 2024 Keurig Dr Pepper agreed to buy it for around $990m.
Underneath all four is one shift the giants are now reformulating around: GLP-1 drugs. Users eat substantially fewer calories, and EY-Parthenon estimates the change in diet could cost the snack category up to $12bn over the next decade. Nestlé launched Vital Pursuit with GLP-1 support badging on the pack. PepsiCo, which initially played down the impact, has since added high-protein and fibre variants across Doritos, SunChips and Smartfood. Read that against David’s protein-per-calorie claim and it stops looking like a nutrition fad. The challengers were early to the same shift the giants are now spending billions to catch up with.
Then there is the cautionary one. Prime, the hydration brand from Logan Paul and KSI, was projected to pass $1.2bn in sales in 2023 and then fell hard, with UK revenue dropping more than 70% in 2024. Prime had enormous attention and no durable reason to buy the second bottle. That is the difference between a brand and a moment. Attention gets the first purchase; a real reason to repurchase is what builds a business.
What challengers can steal from the giants, and the giants from challengers
Put the two lists side by side and the lessons run both ways.
From the giants, steal distribution discipline and category focus. They do not win because their products are dramatically better. They win because they are everywhere a shopper looks and they rarely launch on a whim. A small brand cannot match their footprint, but it can copy the discipline: pick one category, earn one shelf, get repeat purchase working before chasing the next thing.
From the challengers, the giants are trying to buy what they cannot build in-house: the ability to spot a shift early and give people a reason to care that is not just price. Poppi and Olipop rode a genuine change in what people wanted from a soft drink. David gave a tangible product reason. Liquid Death and Ghost built identity. None of that requires a giant’s budget. It requires being right about something before it is obvious.
There is a rough shape to what actually gets bought, and it is visible in all four deals above. The target created or redefined a category rather than joining one. It grew fast enough to read as a threat rather than a curiosity. And it sat on a distribution gap the parent could close in a single quarter. That last one carries the most weight, because it is the reason a giant pays a premium instead of just launching a copy. If you are building towards an exit, build towards being the most obviously missing piece of somebody else’s portfolio, not the biggest possible standalone brand.
Which is the real through-line among the challengers that lasted. They validated the demand before they bet the business on it. Poppi and Olipop were riding a behaviour that was already visible in search trends and category data. Prime was riding hype. The difference does not show up in year one, when the launch buzz carries everyone. It shows up in year two, when the only thing keeping a brand alive is whether people actually want it again.
The good news for a small brand is that finding out whether the demand is real is now cheap. You do not need a giant’s research budget to pressure-test an idea before you commit stock. A monadic concept test tells you whether an idea stands on its own rather than just beating the option next to it. A simple price sensitivity study tells you what people will actually pay, in context, next to the competition. A short voice-of-customer programme tells you why they would choose you, in their own words, so you know what to put on the pack.
This is the job we built TestFeed for. You can test a concept, a pack, an in-context price, a claim, a name or an ad against your target audience before you commit stock or spend, and get back a purchase-intent read, the shoppers’ reasons in their own words, and a clear next move, in days rather than weeks. It is directional signal, not a guaranteed sales number, and it will not tell you how something tastes. But it is the difference between launching on evidence and launching on a hunch, and it is the work we have done with challenger brands like Bae Juice and Sol Bevi.
Frequently asked questions
What is a CPG brand?
A CPG brand is a consumer packaged goods brand: everyday products that people buy often and use up quickly, such as food, drinks, personal care and household items. The distinction worth keeping straight is between a CPG company and a CPG brand. A company like Procter & Gamble is a portfolio owner; the brands it owns, such as Tide, Gillette and Pampers, are what shoppers actually recognise and buy.
What are the biggest CPG companies in 2026?
Ranked by revenue, the biggest CPG companies are Nestlé, PepsiCo, Procter & Gamble, Unilever and Coca-Cola, followed by the likes of AB InBev, JBS, L’Oréal, Mondelez, Danone and Kraft Heinz. Nestlé reported CHF 91.35bn in sales in 2024, PepsiCo $91.85bn, P&G $84.3bn in its 2025 financial year, Unilever €60.8bn and Coca-Cola $47.1bn.
Which challenger CPG brands are growing fastest?
In 2024 to 2025 the standout challengers were prebiotic sodas Olipop and Poppi, canned water brand Liquid Death, protein bar brand David and energy brand Ghost. Olipop reached around $400m in sales and a $1.85bn valuation, PepsiCo bought Poppi for $1.95bn, Liquid Death hit $333m in revenue, and David reached a $725m valuation within nine months of launch.
What can a small brand learn from the top CPG brands?
From the giants, distribution discipline and category focus: they win on scale and supply chain, not on any single clever product. From the challengers, category creation and a clear reason to care, launched fast. The trait shared by the challengers that lasted is that they validated real demand cheaply before committing money, rather than betting the business on a hunch or on hype.
Where a small brand actually wins
One player is missing from the giants-versus-challengers framing, and it is the one squeezing the middle hardest: the retailer, whose own label has been quietly taking share from mid-tier brands throughout. That sharpens the advice rather than changing it. You cannot out-scale Nestlé and you cannot out-price a supermarket’s own brand, so identity and category creation are not one option among several. They are the doors still open.
Do not try to out-Nestlé Nestlé. The giants win on scale you cannot buy and relationships you cannot shortcut. You win the way Olipop and David did: by being right about a shift the giants are too big to chase, and by being right early enough that you have built the brand before they turn up with a chequebook.
The cheapest insurance against being wrong is to check before you commit. Validate the demand, the price and the reason to care while the only thing at stake is a bit of research time, not a warehouse of stock. If you are getting ready to put something on a shelf, my product launch strategy guide picks up exactly where this one leaves off.
